C
ClouDr Group Ltd
HKEX:9955
ClouDr Group Ltd
HKEX:9955
Price:
0.72
HKD
2.86%
Market Closed
Market Cap:
HK$464.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
ClouDr Group Ltd
HKEX:9955
|
CN |
|
O
|
OVB Holding AG
DUS:O4B
|
DE |
|
G
|
Genes Tech Group Holdings Co Ltd
HKEX:8257
|
TW |
|
Green Chemical Co Ltd
KRX:083420
|
KR |
|
A
|
Aebi Schmidt Holding AG
NASDAQ:AEBI
|
CH |
|
Sky Energy Indonesia Tbk PT
IDX:JSKY
|
ID |
|
B
|
BGMC International Ltd
HKEX:1693
|
MY |
|
Yamaya Corp
TSE:9994
|
JP |
|
B
|
Bloomios Inc
OTC:BLMS
|
US |
|
Jiangsu Hagong Intelligent Robot Co Ltd
SZSE:000584
|
CN |
|
D
|
Dongkuk Industries Co Ltd
KOSDAQ:005160
|
KR |
|
C
|
Chi Ho Development Holdings Ltd
HKEX:8423
|
HK |
|
A
|
Adamant Holding Inc
CNSX:ADMT
|
CA |
Multiples-Based Value
The Multiples-Based Value for ClouDr Group Ltd (9955) under the Base Case is hidden HKD. Compared with the current market price of 0.72 HKD, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ClouDr Group Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
ClouDr Group Ltd Competitors
ClouDr Group Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
C
|
ClouDr Group Ltd
HKEX:9955
|
422.7m HKD | 0.2 | -0.4 | 0.3 | 0.3 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
105.4B USD | 0.3 | 24.6 | 17.3 | 19.4 | |
| US |
|
Cencora Inc
NYSE:COR
|
62.4B USD | 0.2 | 38.7 | 13.7 | 17.3 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
62.3B USD | 0.2 | 38.3 | 13.6 | 17.1 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
50.2B USD | 0.2 | 30.6 | 14.8 | 19.2 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.7B AUD | 2.7 | 33.8 | 25.1 | 25.1 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64.1B CNY | 0.2 | 11.2 | 8.7 | 8.7 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63B CNY | 1.5 | 17 | 13.2 | 13.2 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.5B USD | 0.7 | 21.8 | 10.8 | 15.2 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65.3B HKD | 0.1 | 8.2 | 0.7 | 0.9 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
